{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T10:13:33Z","timestamp":1776939213763,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.clgc.2025.102350","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T11:54:02Z","timestamp":1744372442000},"page":"102350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Clinical Trajectory of Prostate Cancer Patients Harboring Rare Histological Subtypes\u2014A Retrospective Cohort Trial"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8260-9501","authenticated-orcid":false,"given":"Nastasiia","family":"Artamonova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon","family":"Galle\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1064-0098","authenticated-orcid":false,"given":"Hannes","family":"Neuwirt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Heimd\u00f6rfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Ladurner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3241-3183","authenticated-orcid":false,"given":"Giulia","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eberhard","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Puhr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmin","family":"Bektic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Horninger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Heidegger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clgc.2025.102350_bib0001","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.eururo.2023.03.014","article-title":"Impact of epithelial histological types, subtypes, and growth patterns on oncological outcomes for patients with nonmetastatic prostate cancer treated with curative intent: a systematic review","volume":"84","author":"Marra","year":"2023","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.clgc.2025.102350_bib0002","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.eururo.2022.07.002","article-title":"The 2022 World Health Organization classification of tumors of the urinary system and male genital organs-Part B: prostate and urinary tract tumors","volume":"82","author":"Netto","year":"2022","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.clgc.2025.102350_bib0003","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol."},{"issue":"1","key":"10.1016\/j.clgc.2025.102350_bib0004","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1309\/AJCPZ7WBU9YXSJPE","article-title":"Digital quantification of five high-grade prostate cancer patterns, including the cribriform pattern, and their association with adverse outcome","volume":"136","author":"Iczkowski","year":"2011","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.clgc.2025.102350_bib0005","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00428-015-1809-5","article-title":"Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy","volume":"467","author":"Keefe","year":"2015","journal-title":"Virchows Arch"},{"issue":"2","key":"10.1016\/j.clgc.2025.102350_bib0006","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.eururo.2019.07.051","article-title":"Improved prostate cancer biopsy grading by incorporation of invasive cribriform and intraductal carcinoma in the 2014 grade groups","volume":"77","author":"van Leenders","year":"2020","journal-title":"Eur Urol"},{"issue":"8","key":"10.1016\/j.clgc.2025.102350_bib0007","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/PAS.0000000000001497","article-title":"The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on grading of prostatic carcinoma","volume":"44","author":"van Leenders","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.clgc.2025.102350_bib0008","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/pros.23818","article-title":"The influence of the presence of intraductal carcinoma of the prostate on the grade group system\u2019s prognostic performance","volume":"79","author":"Kato","year":"2019","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.clgc.2025.102350_bib0009","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/pros.23438","article-title":"Prognostic parameter for high risk prostate cancer patients at initial presentation","volume":"78","author":"Kato","year":"2018","journal-title":"Prostate"},{"issue":"5","key":"10.1016\/j.clgc.2025.102350_bib0010","doi-asserted-by":"crossref","first-page":"519","DOI":"10.4103\/aja.aja_117_19","article-title":"Intraductal carcinoma of the prostate in prostate biopsy samples: correlation with aggressive pathological features after radical prostatectomy and prognostic value in high-risk prostate cancer","volume":"22","author":"Zhu","year":"2020","journal-title":"Asian J Androl"},{"issue":"1","key":"10.1016\/j.clgc.2025.102350_bib0011","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13014-019-1267-3","article-title":"Retrospective study on the benefit of adjuvant radiotherapy in men with intraductal carcinoma of prostate","volume":"14","author":"Trinh","year":"2019","journal-title":"Radiat Oncol"},{"issue":"4","key":"10.1016\/j.clgc.2025.102350_bib0012","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/pros.24100","article-title":"Prostatic ductal adenocarcinoma variant predicts worse pathological and oncological outcomes: insight from over 1000 consecutive patients from a large prospective uro-oncology registry","volume":"81","author":"Tan","year":"2021","journal-title":"Prostate"},{"issue":"6","key":"10.1016\/j.clgc.2025.102350_bib0013","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/bju.14831","article-title":"High ductal proportion predicts biochemical recurrence in prostatic ductal adenocarcinoma","volume":"124","author":"Harkin","year":"2019","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.clgc.2025.102350_bib0014","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/00000478-200105000-00008","article-title":"Prostatic foamy gland carcinoma with aggressive behavior: clinicopathologic, immunohistochemical, and ultrastructural analysis","volume":"25","author":"Tran","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.clgc.2025.102350_bib0015","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.5858\/arpa.2022-0165-OA","article-title":"High-grade desmoplastic foamy gland prostatic adenocarcinoma","volume":"147","author":"Gao","year":"2023","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"10.1016\/j.clgc.2025.102350_bib0016","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.anndiagpath.2014.07.002","article-title":"Foamy gland carcinoma in core needle biopsies of the prostate: clinicopathologic and immunohistochemical study of 56 cases","volume":"18","author":"Koca","year":"2014","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.clgc.2025.102350_bib0017","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.3389\/fonc.2019.01467","article-title":"Mucinous prostate cancer shows similar prognosis to typical prostate acinar carcinoma: a large population-based and propensity score-matched study","volume":"9","author":"Zhao","year":"2019","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102350_bib0018","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/ijlh.12426","article-title":"Comparison between different d-Dimer cutoff values to assess the individual risk of recurrent venous thromboembolism: analysis of results obtained in the DULCIS study","volume":"38","author":"Palareti","year":"2016","journal-title":"Int J Lab Hematol"},{"issue":"7","key":"10.1016\/j.clgc.2025.102350_bib0019","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/PAS.0b013e318160edaf","article-title":"High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases","volume":"32","author":"Tavora","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clgc.2025.102350_bib0020","first-page":"93","article-title":"The Eighth edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA: a cancer journal for clinicians"},{"issue":"4","key":"10.1016\/j.clgc.2025.102350_bib0021","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00428-017-2276-y","article-title":"Eighth edition of the UICC Classification of Malignant Tumours: an overview of the changes in the pathological TNM classification criteria\u2014What has changed and why?","volume":"472","author":"Bertero","year":"2018","journal-title":"Virchows Arch"},{"issue":"6","key":"10.1016\/j.clgc.2025.102350_bib0022","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.eururo.2015.12.010","article-title":"The role of prostate-specific antigen persistence after radical prostatectomy for the prediction of clinical progression and cancer-specific mortality in node-positive prostate cancer patients","volume":"69","author":"Bianchi","year":"2016","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.clgc.2025.102350_bib0023","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.euf.2019.06.004","article-title":"Biochemical recurrence in prostate cancer: the European Association of Urology Prostate Cancer Guidelines Panel Recommendations","volume":"6","author":"Van den Broeck","year":"2020","journal-title":"Eur Urol Focus"},{"issue":"1","key":"10.1016\/j.clgc.2025.102350_bib0024","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41379-020-0625-x","article-title":"Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patients","volume":"34","author":"Hollemans","year":"2021","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.clgc.2025.102350_bib0025","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/his.14064","article-title":"Clinical outcome comparison of grade group 1 and Grade Group 2 prostate cancer with and without cribriform architecture at the time of radical prostatectomy","volume":"76","author":"Hollemans","year":"2020","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.clgc.2025.102350_bib0026","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/his.13747","article-title":"Concordance of biopsy and prostatectomy diagnosis of intraductal and cribriform carcinoma in a prospectively collected data set","volume":"74","author":"Masoomian","year":"2019","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.clgc.2025.102350_bib0027","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3346\/jkms.2015.30.4.385","article-title":"Clinicopathological features of prostate ductal carcinoma: matching analysis and comparison with prostate acinar carcinoma","volume":"30","author":"Kim","year":"2015","journal-title":"J Korean Med Sci"},{"issue":"4","key":"10.1016\/j.clgc.2025.102350_bib0028","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.juro.2016.11.104","article-title":"Prognostic significance of the proportion of ductal component in ductal adenocarcinoma of the prostate","volume":"197","author":"Jang","year":"2017","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.clgc.2025.102350_bib0029","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/modpathol.2014.116","article-title":"Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer","volume":"28","author":"Kweldam","year":"2015","journal-title":"Mod Pathol an Off J United States Can Acad Pathol Inc"},{"issue":"8","key":"10.1016\/j.clgc.2025.102350_bib0030","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/pros.23977","article-title":"Expansile cribriform gleason pattern 4 has histopathologic and molecular features of aggressiveness and greater risk of biochemical failure compared to glomerulation gleason pattern 4","volume":"80","author":"Greenland","year":"2020","journal-title":"Prostate"},{"issue":"9","key":"10.1016\/j.clgc.2025.102350_bib0031","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.ejca.2012.02.003","article-title":"Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapy","volume":"48","author":"Van der Kwast","year":"2012","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.clgc.2025.102350_bib0032","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/pros.24100","article-title":"Prostatic ductal adenocarcinoma variant predicts worse pathological and oncological outcomes: insight from over 1000 consecutive patients from a large prospective uro-oncology registry","volume":"81","author":"Tan","year":"2021","journal-title":"Prostate"},{"key":"10.1016\/j.clgc.2025.102350_bib0033","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ejca.2020.12.030","article-title":"Ductal variant prostate carcinoma is associated with a significantly shorter metastasis-free survival","volume":"148","author":"Chow","year":"2021","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.clgc.2025.102350_bib0034","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/his.13278","article-title":"Mucinous adenocarcinoma of prostate and prostatic adenocarcinoma with mucinous components: a clinicopathological analysis of 143 cases","volume":"71","author":"Samaratunga","year":"2017","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.clgc.2025.102350_bib0035","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00428-014-1636-0","article-title":"Immunohistochemical profile of ductal adenocarcinoma of the prostate","volume":"465","author":"Seipel","year":"2014","journal-title":"Virchows Arch"},{"issue":"3","key":"10.1016\/j.clgc.2025.102350_bib0036","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.euf.2017.12.003","article-title":"Integrative genomic analysis of coincident cancer foci implicates CTNNB1 and PTEN alterations in ductal prostate cancer","volume":"5","author":"Gillard","year":"2019","journal-title":"Eur Urol Focus"},{"issue":"23","key":"10.1016\/j.clgc.2025.102350_bib0037","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15235512","article-title":"Molecular alterations in intraductal carcinoma of the prostate","volume":"15","author":"Bernhardt","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.clgc.2025.102350_bib0038","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12885-017-3976-z","article-title":"Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations","volume":"18","author":"B\u00f6ttcher","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clgc.2025.102350_bib0039","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ejca.2021.01.027","article-title":"Association between BRCA2 alterations and intraductal and cribriform histologies in prostate cancer","volume":"147","author":"Lozano","year":"2021","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.clgc.2025.102350_bib0040","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/bco2.212","article-title":"Genomic alterations in neuroendocrine prostate cancer: a systematic review and meta-analysis","volume":"4","author":"Chen","year":"2023","journal-title":"BJUI compass"},{"issue":"6","key":"10.1016\/j.clgc.2025.102350_bib0041","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/PAS.0000000000000208","article-title":"Proposed morphologic classification of prostate cancer with neuroendocrine differentiation","volume":"38","author":"Epstein","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.clgc.2025.102350_bib0042","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.clgc.2025.102350_bib0043","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.21037\/tau-19-763","article-title":"Aberrant integrin \u03b1v and \u03b15 expression in prostate adenocarcinomas and bone-metastases is consistent with a bone-colonizing phenotype","volume":"9","author":"Connell","year":"2020","journal-title":"Transl Androl Urol"},{"issue":"7","key":"10.1016\/j.clgc.2025.102350_bib0044","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41379-019-0221-0","article-title":"Three-dimensional analysis reveals two major architectural subgroups of prostate cancer growth patterns","volume":"32","author":"Verhoef","year":"2019","journal-title":"Mod Pathol an Off J United States Can Acad Pathol Inc"},{"issue":"9","key":"10.1016\/j.clgc.2025.102350_bib0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25094818","article-title":"Unveiling the genomic landscape of intraductal carcinoma of the prostate using spatial gene expression analysis","volume":"25","author":"Watanabe","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.clgc.2025.102350_bib0046","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.eururo.2008.02.035","article-title":"Evaluation of prostate cancer detection with ultrasound real-time elastography: a comparison with step section pathological analysis after radical prostatectomy","volume":"54","author":"Salomon","year":"2008","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102350_bib0047","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1464-410X.2007.06851.x","article-title":"Real-time elastography for detecting prostate cancer: preliminary experience","volume":"100","author":"Pallwein","year":"2007","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.clgc.2025.102350_bib0048","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on prostate Cancer-2024 update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.clgc.2025.102350_bib0049","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41391-022-00543-4","article-title":"Real-world use of MRI for risk stratification prior to prostate biopsy","volume":"26","author":"Siddiqui","year":"2023","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.clgc.2025.102350_bib0050","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.urology.2018.04.007","article-title":"Adoption of prebiopsy magnetic resonance imaging for men undergoing prostate biopsy in the United States","volume":"117","author":"Liu","year":"2018","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.clgc.2025.102350_bib0051","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.juro.2018.01.071","article-title":"Evolving use of prebiopsy prostate magnetic resonance imaging in the Medicare population","volume":"200","author":"Rosenkrantz","year":"2018","journal-title":"J Urol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325000515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325000515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T19:52:31Z","timestamp":1752609151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767325000515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1558767325000515"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102350","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Clinical Trajectory of Prostate Cancer Patients Harboring Rare Histological Subtypes\u2014A Retrospective Cohort Trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102350","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102350"}}